⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9440815 | 0.97 | — | — | |
| Iodide SCHEMBL20969953 | 0.97 | — | — | |
| SCHEMBL6287867 | 0.77 | — | — | |
| SCHEMBL24386522 | 0.75 | — | — | |
| SCHEMBL45302 | 0.73 | — | — | |
| SCHEMBL21630405 | 0.73 | — | — | |
| SCHEMBL6408429 | 0.71 | — | — | |
| SCHEMBL13719025 | 0.71 | — | — | |
| SCHEMBL2831782 | 0.69 | — | — | |
| SCHEMBL835304 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0931082-A4 | NODULISPORIC ACID DERIVATIVES | MERCK & CO INC (US) | 1999-11-17 | — | — | EP | claimed |
| EP-0931082-A1 | NODULISPORIC ACID DERIVATIVES | Merck & Co., Inc. (a New Jersey corp.) (US) | 1999-07-28 | — | — | EP | claimed |
| WO-1998012196-A1 | NODULISPORIC ACID DERIVATIVES | MERCK & CO., INC. (US) | 1998-03-26 | — | — | WO | claimed |
| JP-10101807-A | — | — | None | — | — | JP | disclosed |
| US-20250339406-A1 | NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2025-11-06 | — | — | US | disclosed |
| US-12364688-B2 | NSD family inhibitors and methods of treatment therewith | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-07-22 | — | — | US | disclosed |
| US-20240245645-A1 | ASH1L INHIBITORS AND METHODS AND TREATMENT THEREWITH | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-07-25 | — | — | US | disclosed |
| US-11883381-B2 | ASH1L inhibitors and methods of treatment therewith | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-01-30 | — | — | US | disclosed |
| CN-114874366-B | Multi-center supported metalloporphyrin complex and preparation method thereof, and preparation method of carbon dioxide-based polymer | 中国科学院长春应用化学研究所 | 2023-06-20 | — | — | CN | disclosed |
| US-20230046569-A1 | NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2023-02-16 | — | — | US | disclosed |
| CN-114874366-A | Multi-center loaded metalloporphyrin complex and preparation method thereof as well as preparation method of carbon dioxide-based polymer | 中国科学院长春应用化学研究所 | 2022-08-09 | — | — | CN | disclosed |
| EP-3720439-A1 | NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH | The Regents Of The University Of Michigan (US) | 2020-10-14 | — | — | EP | disclosed |
| US-20190183865-A1 | NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2019-06-20 | — | — | US | disclosed |
| WO-2019113469-A1 | NSD FAMILY INHIBITORS AND METHODS OF TREATMENT THEREWITH | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2019-06-13 | — | — | WO | disclosed |
| US-20190142799-A1 | ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2019-05-16 | — | — | US | disclosed |
| EP-3454945-A1 | ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH | The Regents Of The University Of Michigan (US) | 2019-03-20 | — | — | EP | disclosed |
| WO-2017197240-A1 | ASH1L INHIBITORS AND METHODS OF TREATMENT THEREWITH | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2017-11-16 | — | — | WO | disclosed |
| EP-2158198-A2 | NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | AstraZeneca AB (SE) | 2010-03-03 | — | — | EP | disclosed |
| WO-2008130320-A2 | NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN | ASTRAZENECA AB (SE) | 2008-10-30 | — | — | WO | disclosed |
| JP-H10101807-A | PRODUCTION OF WATER-REPELLENT RESIN COMPOSITE MATERIAL AND WATER-REPELLENT RESIN COMPOSITE MATERIAL | OSAKA GAS CO LTD | 1998-04-21 | — | — | JP | disclosed |